AAAAAA
Results:
1-10
|
Results: 10
Authors:
HAWORTH SJ
CHRISTOFALO B
ANDERSON RD
DUNKLE LM
Citation: Sj. Haworth et al., A SINGLE-DOSE STUDY TO ASSESS THE PENETRATION OF STAVUDINE INTO HUMANCEREBROSPINAL-FLUID IN ADULTS, Journal of acquired immune deficiency syndromes and human retrovirology, 17(3), 1998, pp. 235-238
Authors:
KLINE MW
FLETCHER CV
FEDERICI ME
HARRIS AT
EVANS KD
RUTKIEWICZ VL
SHEARER WT
DUNKLE LM
Citation: Mw. Kline et al., COMBINATION THERAPY WITH STAVUDINE AND DIDANOSINE IN CHILDREN WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - PHARMACOKINETIC PROPERTIES, SAFETY, AND IMMUNOLOGICAL AND VIROLOGICAL EFFECTS, Pediatrics, 97(6), 1996, pp. 886-890
Authors:
KLINE MW
FLETCHER CV
FEDERICI ME
HARRIS AT
EVANS KD
RUTKIEWICZ VL
SHEARER WT
DUNKLE LM
Citation: Mw. Kline et al., COMBINATION THERAPY WITH STAVUDINE (D4T) AND DIDANOSINE (DDI) IN CHILDREN WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION, Pediatric research, 39(4), 1996, pp. 1039-1039
Authors:
KLINE MW
DUNKLE LM
CHURCH JA
GOLDSMITH JC
HARRIS AT
FEDERICI ME
SCHULTZE ME
WOODS L
LOEWEN DF
KAUL S
CROSS A
RUTKIEWICZ VL
ROSENBLATT HM
HANSON IC
SHEARER WT
Citation: Mw. Kline et al., A PHASE I II EVALUATION OF STAVUDINE (D4T) IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION/, Pediatrics, 96(2), 1995, pp. 247-252
Authors:
DUNKLE LM
Citation: Lm. Dunkle, LONG-TERM SURVIVORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION, The New England journal of medicine, 332(24), 1995, pp. 1647-1647
Authors:
ANDERSON RE
DUNKLE LM
SMALDONE L
ADLER M
WIRTZ C
KRIESEL D
CROSS A
MARTIN RR
Citation: Re. Anderson et al., DESIGN AND IMPLEMENTATION OF THE STAVUDINE PARALLEL-TRACK PROGRAM, The Journal of infectious diseases, 171, 1995, pp. 118-122
Authors:
MURRAY HW
SQUIRES KE
WEISS W
SLEDZ S
SACKS HS
HASSETT J
CROSS A
ANDERSON RE
DUNKLE LM
Citation: Hw. Murray et al., STAVUDINE IN PATIENTS WITH AIDS AND AIDS-RELATED COMPLEX - AIDS CLINICAL-TRIALS GROUP-089, The Journal of infectious diseases, 171, 1995, pp. 123-130
Authors:
PETERSEN EA
RAMIREZRONDA CH
HARDY WD
SCHWARTZ R
SACKS HS
FOLLANSBEE S
PETERSON DM
CROSS A
ANDERSON RE
DUNKLE LM
Citation: Ea. Petersen et al., DOSE-RELATED ACTIVITY OF STAVUDINE IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, The Journal of infectious diseases, 171, 1995, pp. 131-139
Authors:
GRASELA TH
WALAWANDER CA
BELTANGADY M
KNUPP CA
MARTIN RR
DUNKLE LM
BARBHAIYA RH
PITTMAN KA
DOLIN R
VALENTINE FT
LIEBMAN HA
Citation: Th. Grasela et al., ANALYSIS OF POTENTIAL RISK-FACTORS ASSOCIATED WITH THE DEVELOPMENT OFPANCREATITIS IN PHASE-I PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX RECEIVING DIDANOSINE, The Journal of infectious diseases, 169(6), 1994, pp. 1250-1255
Authors:
SPRUANCE SL
PAVIA AT
PETERSON D
BERRY A
POLLARD R
PATTERSON TF
FRANK I
REMICK SC
THOMPSON M
MACARTHUR RD
MOREY GE
RAMIREZRONDA CH
BERNSTEIN BM
SWEET DE
CRANE L
PETERSON EA
PACHUCKI CT
GREEN SL
BRAND J
RIOS A
DUNKLE LM
CROSS A
BROWN MJ
INGRAHAM P
GUGLIOTTI R
SCHINDZIELORZ AH
SMALDONE L
BECKER T
BIA FJ
BUJWIT C
DONABEDIAN H
EVANS TG
FIELLIN M
KAEMPFER S
OKEEFE JP
LIPTON L
MARK RJ
OTT G
REIMER LG
RIES K
WATERMAN K
WEST MM
Citation: Sl. Spruance et al., DIDANOSINE COMPARED WITH CONTINUATION OF ZIDOVUDINE IN HIV-INFECTED PATIENTS WITH SIGNS OF CLINICAL DETERIORATION WHILE RECEIVING ZIDOVUDINE - A RANDOMIZED, DOUBLE-BLIND CLINICAL-TRIAL, Annals of internal medicine, 120(5), 1994, pp. 360-368
Risultati:
1-10
|